The appellant, a standardbred licensee and trainer, appealed the penalty imposed after his horse tested positive for the Class II drug Reserpine.
The initial penalty was a six-month suspension and a $3,000 fine.
The Commission considered mitigating factors, including the appellant's clear record, the therapeutic intent of the administration, and financial hardship.
The Commission reduced the fine to $1,500 and stayed the unexpired portion of the suspension, noting the principles of penalty assessment and the appellant's ability to pay.